论文部分内容阅读
目的探讨白葡奈菌片对儿童反复呼吸道感染合并支气管哮喘的临床疗效。方法将收治的68例反复呼吸道感染合并支气管哮喘的患儿采用随机、双盲法分为两组。两组均采用综合治疗,观察组加服白葡奈菌片,对治疗前后症状、体征、呼吸道感染复发次数进行比较。结果观察组在缓解咳嗽、喘息方面明显优于对照组(P<0.05),在呼吸道感染复发次数方面显著优于对照组(P<0.01)。结论白葡奈菌片防治儿童反复呼吸道感染合并支气管哮喘,可有效缓解症状,预防呼吸道感染,从而减少哮喘发作的次数。
Objective To investigate the clinical efficacy of bilobalide on children with recurrent respiratory tract infection complicated with bronchial asthma. Methods Sixty-eight children with recurrent respiratory tract infection complicated with bronchial asthma were randomly divided into two groups. The two groups were treated with comprehensive treatment, the observation group plus Bai Shuna bacteria tablets before and after treatment of symptoms, signs, respiratory infections, the number of relapse were compared. Results The observation group was significantly better than the control group in relieving cough and wheezing (P <0.05), and was significantly better than the control group in the number of recurrent respiratory tract infections (P <0.01). Conclusion Clarithromycobaripol can prevent recurrent respiratory tract infections in children with bronchial asthma, which can effectively relieve the symptoms and prevent respiratory infections, thus reducing the number of asthma attacks.